Jaime Marshall is now able to enjoy steak for the first time in her life after a life-saving liver transplant from her sister ...
The development of an effective vaccine against the hepatitis C virus (HCV) has posed a significant challenge for decades due ...
Nuvalent, Inc. has promising drugs, zidesamtinib and NVL-655, targeting NSCLC with encouraging data. Read why NUVL stock is a ...
Globally, approximately 58 million people are chronically infected with HCV, resulting in 290,000 annual deaths due to complications such as liver ...
AstraZeneca's supplemental Biologics License Application (sBLA) for IMFINZI® (durvalumab) has been accepted and granted Priority Review in the US for the treatment of patients with muscle-invasive ...
Weight loss methods are changing at an unparalleled rate. What was previously restricted to conventional diets and strenuous ...